REHAB CLINICAL DATA LTD Filleted Accounts Cover
REHAB CLINICAL DATA LTD
Company No. 13133074
Information for Filing with The Registrar
31 January 2025
REHAB CLINICAL DATA LTD Directors Report Registrar
The Director presents his report and the accounts for the year ended 31 January 2025.
Principal activities
The principal activity of the company during the year under review was continued to be Research and experimental development on biotechnology.
Director
The Director who served at any time during the year was as follows:
Suhel Mehmudbhai Patel
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
Suhel Mehmudbhai Patel
Director
31 January 2025
REHAB CLINICAL DATA LTD Balance Sheet Registrar
at
31 January 2025
Company No.
13133074
Notes
2025
2024
£
£
Fixed assets
Tangible assets
4
253507
253507
Current assets
Debtors
5
66,875942
Cash at bank and in hand
25,27885,312
92,15386,254
Creditors: Amount falling due within one year
6
(46,385)
(56,571)
Net current assets
45,76829,683
Total assets less current liabilities
46,02130,190
Net assets
46,02130,190
Capital and reserves
Called up share capital
200200
Profit and loss account
8
45,82129,990
Total equity
46,02130,190
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 31 January 2025 and signed on its behalf by:
Suhel Mehmudbhai Patel
Director
31 January 2025
REHAB CLINICAL DATA LTD Notes to the Accounts Registrar
for the year ended 31 January 2025
1
General information
REHAB CLINICAL DATA LTD is a private company limited by shares and incorporated in England and Wales.
Its registered number is: 13133074
Its registered office is:
66 Stoke Poges Lane,
Slough,
SL1 3PD
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Furniture, fittings and equipment
20% Straight Line
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Foreign currencies
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
Transactions in currencies, other than the functional currency of the Company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. all differences are taken to the profit and loss account. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.
Defined contribution pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.
The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
Provisions
Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.

When payments are eventually made, they are charged to the provision carried in the balance sheet.
3
Employees
2025
2024
Number
Number
The average monthly number of employees (including directors) during the year was:
21
4
Tangible fixed assets
Fixtures, fittings and equipment
Total
£
£
Cost or revaluation
At 1 February 2024
1,0151,015
At 31 January 2025
1,0151,015
Depreciation
At 1 February 2024
508508
Charge for the year
254254
At 31 January 2025
762762
Net book values
At 31 January 2025
253253
At 31 January 2024
507
507
5
Debtors
2025
2024
£
£
Trade debtors
-942
Other debtors
66,875-
66,875942
6
Creditors:
amounts falling due within one year
2025
2024
£
£
Taxes and social security
32,070
16,754
Loans from directors
117-
Other creditors
4,89138,377
Accruals and deferred income
9,3071,440
46,38556,571
7
Share Capital
100 ordinary £1 shares were allocated with aggregated nominal value of £100. 50 ordinary shares were allotted to each Shareholder with nominal value of 1 per share. Additionally, 100 Ordinary-A Shares were issued to director/shareholder.

100 Ordinary Class A £1 shares were issued to the share holders.
8
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
9
Dividends
2025
2024
£
£
Dividends for the period:
Dividends paid in the period
-
-
Dividends accrued at the period end
76,000
51,000
76,000
51,000
Dividends by type:
Non-equity preference dividends
--
Equity dividends
76,00051,000
76,000
51,000
REHAB CLINICAL DATA LTD1313307431 January 202501 February 2024false31 January 2025BTCSoftware AP Solution 2024 11.2.0111.2.01true131330742024-02-012025-01-31131330742025-01-31131330742024-01-3113133074core:WithinOneYear2025-01-3113133074core:WithinOneYear2024-01-3113133074core:ShareCapital2025-01-3113133074core:ShareCapital2024-01-3113133074core:RetainedEarningsAccumulatedLosses2025-01-3113133074core:RetainedEarningsAccumulatedLosses2024-01-3113133074countries:UnitedKingdom2024-02-012025-01-3113133074bus:RegisteredOffice2024-02-012025-01-3113133074core:FurnitureFittingsToolsEquipment2024-02-012025-01-31131330742023-02-012024-01-3113133074core:FurnitureFittingsToolsEquipment2024-02-01131330742024-02-0113133074core:FurnitureFittingsToolsEquipment2025-01-3113133074core:RetainedEarningsAccumulatedLosses2024-02-012025-01-3113133074bus:AllOrdinaryShares2024-02-012025-01-3113133074bus:SmallEntities2024-02-012025-01-3113133074bus:FullAccounts2024-02-012025-01-3113133074bus:AuditExempt-NoAccountantsReport2024-02-012025-01-3113133074bus:Director12024-02-012025-01-3113133074bus:PrivateLimitedCompanyLtd2024-02-012025-01-31iso4217:GBPxbrli:pure